Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Immunotope

Immunotope?uq=gJQ7UQwH
2002 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of immunotherapy products created for the treatment and prevention of cancer and chronic viral infections. The company's immunotherapy platform provides the ideal combination of technologies for successful immunotherapy, use the exquisite sensitivity and specificity of the immune system for early detection of cancer, provide innovative tools and services for collaborative development of novel drug and diagnostic products, enabling patients with effective treatments that destroy tumors and prevent metastasis.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • The Pennsylvania Biotechnology Center
  • 3805 Old Easton Road
  • Doylestown, PA 18901
  • United States

+1 (251) 000-0000

Immunotope Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Immunotope‘s full profile, request access.

Request full access to PitchBook

Immunotope Executive Team (2)

Name Title Board
Seat
Contact
Info
Ramila Philip Ph.D Co-Founder, President & Chief Scientific Officer
Mohan Philip Ph.D Chief Operating Officer & Co-Founder